Showing 191-200 of 7612 results for "".
DermWireTV: Dupixent for Kids; Epsolay Launch; Scleroderma Awareness; Chicago Derms Celebrate Diversity
https://practicaldermatology.com/topics/practice-management/dermwiretv-dupixent-for-kids-epsolay-launch-scleroderma-awareness-chicago-derms-celebrate-diversity/20100/Epsolay (benzoyl peroxide 5%) Cream from Galderma is now available for the topical treatment of rosacea. It was developed by Sol-Gel. Dupixent from Sanofi and Regeneron is now the only biologic medicine FDA approved for use from infancy through adulthood for the management of atopic dermatitis. JuneEnsuring Excellent Care Across LGBTQ and Sexual Minority Patients
https://practicaldermatology.com/topics/practice-management/ensuring-excellent-care-across-lgbtq-and-sexual-minority-patients/20077/The session on LGBTQ and sexual gender minority health covered a range of topics including both clinical care as well as terminology, structures, and framework. Klint Peebles, MD talks about the importance of providing excellent dermatologic care as patients face disparities and challenges in accessUnintended Consequences: Face Masks and Cosmetic Healing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/unintended-consequences-face-masks-and-cosmetic-healing-1/23612/Wearing a face covering to reduce risk of COVID-19 may compromise healing from cosmetic surgery. Should lower face procedures be postponed?Biologics for Psoriasis and the Impact of the COVID-19 Pandemic
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-and-the-impact-of-the-covid-19-pandemic/23553/A real-world look at how COVID-19 impacted patient care.The Time is Now: Dermatology and Climate Change
https://practicaldermatology.com/topics/practice-management/the-time-is-now-dermatology-and-climate-change/19930/How are global warming and associated changes in weather affecting the presentation of skin diseases? And what opportunities do dermatologists have to help turn the tide of global warning? Misha Rosenbach, MD reviews the science and touches on opportunities for change.Pulse’s CellFX for Dermatologic Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pulses-cellfx-for-dermatologic-applications/23464/A novel technology targets cells to treat warts, sebaceuous hyperplasia, and more.Quality of Care in Atopic Dermatitis: We Can Do Better
https://practicaldermatology.com/topics/atopic-dermatitis/quality-of-care-in-atopic-dermatitis-we-can-do-better/23413/A global report identifies best practices to improve the patient experience and close gaps in care.Scientifically Speaking: Can We Conquer Cellulite?
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-can-we-conquer-cellulite/19872/Treating cellulite has been a challenge, but new and emerging technologies offer hope to overcome this common condition. Host Joel L. Cohen, MD talks with Nazanin Saedi, MD, Endo's Mike McLane, PhD, and Soliton's Wally Klemp.Conversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with HiCrisis Management: Office Operations, Part 2
https://practicaldermatology.com/topics/practice-management/crisis-management-office-operations-part-2/18182/Practice shut downs for COVID-19 will have long-term consequences for medical aesthetic practices. Deirdre Hooper, MD, Ashish Bhatia, MD, Kevin Pinski, MD, and Nancy Samolitis, MD share their predictions with host Neal Bhatia, MD.